After getting engaged, the only words journalist Mrinali Dhembla expected to hear were “I do.” Instead, she was told, “You have cancer.” “When I first heard the words, ‘You have cancer,’ I was obviously very shaken because when you’re in your 20s, you just think that a little disturbance in your bowels isn’t a big … Read more
Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under brand names like Ozempic have helped millions of people lose weight, manage diabetes and improve other health conditions, they are not without risks. Check back for more stories about the lesser-known downsides of … Read more
That’s some serious star power! Shortly after his baffling Pizza Hut commercial dropped, ex-NFL star Tom Brady was named chief wellness officer of eMed, a digital health platform for GLP-1 drugs and more. The seven-time Super Bowl champion, 48, joins the ranks of superstar athletes promoting the blockbuster weight loss and diabetes meds, a head-scratching … Read more
Too good to be true? While blockbuster GLP-1 drugs continue to reach new heights in popularity, they’re not without potential downsides, like bizarre side effects such as “Ozempic feet.” And while they boast impressive blood sugar and weight loss results — average weight lost is nearly 10% over a year — making one mistake could … Read more
Your medication might start tattling on you if you skip a dose. Scientists at MIT have developed a groundbreaking smart pill that can wirelessly report the moment it’s been swallowed, giving doctors a way to monitor whether patients are taking their prescriptions on schedule. It may sound simple, but the stakes are high. Studies show … Read more
New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. With weight loss drugs taking the world by storm, more people are exploring adding these medical marvels to their toolkits. Aside from the impressive results, GLP-1s seem to be increasingly … Read more
The weight-loss drug market just got more crowded — and a lot less painful. The FDA on Monday approved a daily pill version of Novo Nordisk’s Wegovy, making it the first oral GLP-1 obesity treatment cleared for use without injections. “As the first oral GLP-1 treatment for people living with overweight or obesity, the Wegovy … Read more
Without testosterone, Shannon Gonzalez insists she’d probably be divorced. In 2021, her hair was falling out — and her libido was “in the toilet.” She had recently entered medically induced menopause, which unleashed a torrent of symptoms that rocked her career, strained her marriage and shook her sense of self. “Who is this person? I … Read more
For nearly three decades, Viagra has helped men rise to the occasion. The little blue pill increases blood flow to the penis, making it easier to get and keep erections. But women have been left out in the cold, with no real pharmaceutical fix for low libido — until now. In a sultry twist, Viagra’s … Read more
Thirst-zepatide? A cheap, already available pill is being billed as the “Ozempic of alcohol” for its ability to reduce appetites for booze, the way GLP-1 drugs curb food cravings. Naltrexone — which costs about $1.60 a pill when purchased in bulk — decreases the urge for alcohol by blocking opioid receptors in the brain, reducing the dopamine-reward … Read more
Blockbuster weight-loss shots are undergoing a major makeover. Drugs like Zepbound and Wegovy have already taken the US by storm — with the number of Americans using them to slim down more than doubling over the past 18 months. And Big Pharma’s not done cashing in on the weight-loss boom. Drugmakers are readying a new … Read more
A medication meant to lift spirits may be falling flat. New research suggests that an antidepressant commonly prescribed to children and teens may not be as effective as once thought. Now, some experts are raising doubts about whether young people with depression should be taking the drug at all, citing concerns that the risk of … Read more
Sometimes it’s hard to go with the flow. While oral medications are generally considered safer and more convenient than injections or inhalations, sometimes a simple swallow is easier said than done. Pill-induced esophagitis goes down, literally, when a tablet or capsule gets stuck in the narrowing of the esophagus, particularly where it meets the stomach. Swallowing … Read more
There’s a new way to treat alcoholism — and it’s as easy as popping a candy. Clutch, from Oar Health, is said to be the first mint designed to reduce alcohol cravings and curb heavy drinking. Nearly 28 million Americans 12 and older struggle with alcohol use disorder. Adults can take a Clutch once a … Read more
Don’t get tricked by your treats. Americans buy roughly 748 million pounds of candy every Halloween — and more than half of parents admit to swiping a few pieces from their kids’ stash. But there’s more to fear than a trip to the dentist. Americans are expected to spend around $3.9 billion on candy during … Read more
Federal health officials are advising consumers that more than 140,000 bottles of cholesterol medication are being recalled due to “failed dissolution specifications.” Several bottle sizes of Atorvastatin Calcium Tablets, 10-mg (Prescription Only), a medicine used to lower cholesterol and help prevent heart disease, heart attacks and strokes, are impacted by the recall, the Food and … Read more
Women who use Depo-Provera face a higher risk of developing a slow-growing brain tumor, according to a new study that comes as the contraceptive’s maker, Pfizer, faces hundreds of lawsuits claiming that it was aware of the potential risks. Depo-Provera — the brand name for depot medroxyprogesterone acetate (DMPA) — contains the synthetic progestin hormone, … Read more
Slimmer waist, weaker buzz? A new study suggests GLP-1 drugs like Ozempic and Wegovy — commonly used for diabetes and weight loss — may also blunt the effects of alcohol. That might be bad news for casual drinkers, but scientists at Virginia Tech’s Fralin Biomedical Research Institute said it could open the door to a … Read more
Balding might bruise your ego — but your hair-loss fix could be messing with your mind. New research out of Israel suggests that patients using a popular drug for male pattern baldness face a significantly higher risk of mood disorders and suicidal thoughts compared to those who don’t. “The evidence is no longer anecdotal,” Dr. … Read more
Critical care nurse Janet Kerrigan was stunned to discover in 2011 that she had multiple myeloma, an incurable blood cancer, and she only had a year or two to live. A crucial stem cell transplant in 2012 prolonged her life — but her private insurance carrier stuck her with 20% of the nearly million-dollar tab. … Read more